Price Alert

Hims & Hers Health Inc. (HIMS)

NYSE: HIMS · Real-Time Price · USD

55.52

3.76 (7.26%)

At close: Sep 12, 2025, 3:59 PM

55.00

-0.94%

After-hours: Sep 12, 2025, 07:58 PM EDT

7.26% (1D)

Bid	55.19
Market Cap	12.08B
Revenue (ttm)	2.01B
Net Income (ttm)	193.6M
EPS (ttm)	0.79
PE Ratio (ttm)	70.28
Forward PE	60.49
Analyst	Hold

Ask	55.39
Volume	33,787,581
Avg. Volume (20D)	35,812,637
Open	51.03
Previous Close	51.76
Day's Range	50.25 - 55.93
52-Week Range	15.73 - 72.98
Beta	2.14

About HIMS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol HIMS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for HIMS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Hims & Hers Health Inc. is scheduled to release its earnings on Nov 3, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 days ago New

+8.33%

Hims & Hers Health shares are trading higher follo... Unlock content with Pro Subscription

3 days ago

-0.02%

Hims & Hers Health shares are trading higher following a report suggesting the company plans on launching offerings for men with low testosterone.

News

23 hours ago · zacks.com

Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?

HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.

2 days ago · seekingalpha.com

Hims & Hers Looks Like Hyper Growth At A Reasonable Price

Hims is now a GARP stock, combining rapid revenue and subscriber growth with a lower, fair valuation after a recent selloff. The company's scalable model, product launches, and global expansion plans ...

2 days ago · benzinga.com

Hims & Hers Bets On Hormonal Health To Revive Investor Confidence

Hims & Hers Health Inc. HIMS launched a new category in men's health on Wednesday, offering access to affordable and personalized treatment plans for low testosterone.

3 days ago · seekingalpha.com

Hims & Hers: The Next Chapter For Investors

Revenue is scaling rapidly, from $150M in 2020 to ~$2.3B expected in 2025. Over 90% of revenue is recurring subscriptions, ensuring stability and visibility. The vertically integrated model builds a b...

3 days ago · reuters.com

Hims & Hers launches treatment plans for low testosterone

Hims & Hers Health said on Wednesday it is launching a new category in men's health, offering access to personalized treatment plans for low testosterone.

3 days ago · businesswire.com

Hims Launches New Category in Men's Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new category in men's health, offering access to innova...

3 days ago · wsj.com

Hims & Hers Health Expands Testosterone Offerings

Hims & Hers Health is launching treatments for low testosterone on its telehealth platform, venturing deeper into a category often marred by stigma, according to its chief executive.

4 days ago · marketwatch.com

Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted.

President Donald Trump's administration on Tuesday rolled out an executive action aimed at limiting direct-to-consumer advertising for pharmaceuticals, with officials saying a recent Hims & Hers Healt...

4 days ago · zacks.com

Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $47.79, marking a -3.73% move from the previous day.

1 week ago · seekingalpha.com

Hims & Hers Health: At The Intersection Of Secular Megatrends

Hims & Hers Health, Inc. remains a Strong Buy as it is well-positioned to capitalize on secular wellness and digital health trends favored by younger generations. The company boasts stellar fundamenta...

Load More News